← Back to all trials
Recruiting
NCT06376097
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Conditions: Lung Cancer
Sex: All
Ages: 45 Years – 74 Years
Healthy volunteers: No
Enrollment: 1000
Sponsor: AstraZeneca
Location: Hospital das Clínicas da Faculdade de Medicina de Botucatu (HCFMB) Botucatu São Paulo
Summary
Observational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.
Eligibility Criteria
Inclusion Criteria :
Age between 45 and 74 years old; Smoker with a smoking history of at least 30 pack-years or former smoker who has quit smoking for less than 15 years; Never having participated in a lung cancer screening program ; Signing of the free and informed consent form.
Exclusion Criteria:
Patients with chronic diseases (cardiovascular, pulmonary, hepatic, renal or metabolic) at an advanced stage that limit life expectancy or make it impossible to perform a curative surgical procedure; Patients being treated for tuberculosis or other granulomatous diseases; Patients diagnosed with previous neoplasm(s) that could develop lung metastases; Pregnant women; Patients who, for some reason, are unable to undergo low-dose chest computed tomography; Patients previously submitted to thoracic radiotherapy.
Source: ClinicalTrials.gov (NCT06376097). StuddyBuddy aggregates publicly available trial information.